Guy Macdonald

3.2

3.2

Position	Company	Period
Director	SCYNEXIS Inc	Nov. 27, 2014 -
Director	Tetraphase Pharmaceuticals Inc	Aug. 1, 2019 -
President and Chief Executive Officer, Director	Tetraphase Pharmaceuticals Inc	Jan. 1, 2008 - Aug. 1, 2019

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

SCYNEXIS Inc (SCYX)

Transaction date 21 Dec 2020

Purchase

Price

487.50

Quantity 26,356 +34.1%

Value US$4,347,395

Comments Filing

Idenix Pharmaceuticals LLC (IDIX)

Transaction date 27 Jul 2004

Purchase

Price

411.50

Quantity 4,933 +28.2%

Value US$1,495,345

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2020-12-23	2020-12-21	SCYNEXIS Inc (SCYX)	B Purchase	26,356 +34.1% 487.50 US$4,347,395	26,356 +34.1%	487.50	US$4,347,395
2004-07-29	2004-07-27	Idenix Pharmaceuticals LLC (IDIX)	B Purchase	4,933 +28.2% 411.50 US$1,495,345	4,933 +28.2%	411.50	US$1,495,345